Please enable JavaScript to continue using this application.

Compare $ARMP vs $SPRB | Chartloom

Compare

$ARMP vs $SPRB

Armata Pharmaceuticals Inc · Spruce Biosciences, Inc

ARMP

Armata Pharmaceuticals Inc

SPRB

Spruce Biosciences, Inc

Compare $ARMP vs $SPRB

Comparing Armata Pharmaceuticals Inc and Spruce Biosciences, Inc

ARMPArmata Pharmaceuticals Inc

SPRBSpruce Biosciences, Inc

ARMPArmata Pharmaceuticals Inc

Market cap

$133M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

-19.3%

YTD performance

-44.7%

52W performance

12.7%

FCF yield

-19.4%

SPRBSpruce Biosciences, Inc

Market cap

$121M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-51.4%

52W performance

-72.5%

FCF yield

-35.3%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

ARMP

SPRB

Detailed metrics comparison

ARMP

Armata Pharmaceuticals Inc

SPRB

Spruce Biosciences, Inc

Market Cap

ARMP$133M

SPRB$121M

Enterprise Value

ARMP$393M

SPRB$32M

Price

ARMP$3.63

SPRB$44.05

P/E Ratio

ARMPN/A

SPRBN/A

P/S Ratio

ARMP24.04x

SPRB26.75x

EV/Sales

ARMP70.87x

SPRB8.59x

EV/EBITDA

ARMP0.00x

SPRB0.00x

P/B Ratio

ARMP6.85x

SPRB1.57x

P/FCF Ratio

ARMPN/A

SPRBN/A

EV/FCF

ARMP-15.23x

SPRB-0.75x

PEG Ratio

ARMPN/A

SPRBN/A

Forward P/E (NTM)

ARMPN/A

SPRBN/A

Forward P/S (NTM)

ARMPN/A

SPRBN/A

Revenue (TTM)

ARMP$6M

SPRB$0

Revenue Growth (YoY)

ARMP-19.3%

SPRBN/A

Forward Rev Growth

ARMP-35.3%

SPRB-75.6%

Gross Margin (TTM)

ARMP0.0%

SPRB0.0%

Operating Margin (TTM)

ARMP0.0%

SPRB0.0%

EBITDA Margin (TTM)

ARMP-603.4%

SPRB0.0%

Net Margin (TTM)

ARMP-3467.0%

SPRB0.0%

FCF Margin (TTM)

ARMP-465.3%

SPRBN/A

Net Income (TTM)

ARMP$-192M

SPRB$-51M

FCF (TTM)

ARMP$-26M

SPRB$-43M

EPS (TTM)

ARMP-$3.10

SPRB-$21.14

ROE (TTM)

ARMP-12000.0%

SPRB-15540.0%

ROA (TTM)

ARMP-23569.0%

SPRB-10167.0%

ROIC (TTM)

ARMP-8123.0%

SPRB-14349.0%

Cash

ARMP$24M

SPRB$96M

Debt

ARMP$284M

SPRB$7M

Net Cash/Debt

ARMP$-260M

SPRB$89M

Current Ratio (TTM)

ARMP0.11x

SPRB9.23x

Quick Ratio (TTM)

ARMP0.11x

SPRB8.81x

Debt/Equity (TTM)

ARMP1.38x

SPRB0.08x

Debt/Assets (TTM)

ARMP0.0%

SPRB0.0%

Interest Coverage (TTM)

ARMPN/A

SPRBN/A

Net Debt/EBITDA (TTM)

ARMP0.00x

SPRB0.00x

Beta

ARMP1.66

SPRB3.63

52W Performance

ARMP12.7%

SPRB-72.5%

YTD Performance

ARMP-44.7%

SPRB-51.4%

% from 52W High

ARMP-77.8%

SPRB-77.9%

% from 52W Low

ARMP17.5%

SPRB9.2%

Asset Turnover (TTM)

ARMP0.07x

SPRB0.07x

FCF Yield (TTM)

ARMP-19.4%

SPRB-35.3%

Earnings Yield (TTM)

ARMP-144.2%

SPRB-42.4%

Dividend Yield (TTM)

ARMPN/A

SPRBN/A

Rule of 40

ARMP-484.6

SPRB0.0

EV/GP/RG

ARMPN/A

SPRBN/A

Ticker research

View ARMP research View SPRB research

Metric	ARMP Armata Pharmaceuticals Inc	SPRB Spruce Biosciences, Inc
Market & Valuation
Market Cap	$133M	$121M
Enterprise Value	$393M	$32M
Price	$3.63	$44.05
P/E Ratio	N/A	N/A
P/S Ratio	24.04x	26.75x
EV/Sales	70.87x	8.59x
EV/EBITDA	0.00x	0.00x
P/B Ratio	6.85x	1.57x
P/FCF Ratio	N/A	N/A
EV/FCF	-15.23x	-0.75x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$6M	$0
Revenue Growth (YoY)	-19.3%	N/A
Forward Rev Growth	-35.3%	-75.6%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-603.4%	0.0%
Net Margin (TTM)	-3467.0%	0.0%
FCF Margin (TTM)	-465.3%	N/A
Net Income (TTM)	$-192M	$-51M
FCF (TTM)	$-26M	$-43M
EPS (TTM)	-$3.10	-$21.14
ROE (TTM)	-12000.0%	-15540.0%
ROA (TTM)	-23569.0%	-10167.0%
ROIC (TTM)	-8123.0%	-14349.0%
Financial Health
Cash	$24M	$96M
Debt	$284M	$7M
Net Cash/Debt	$-260M	$89M
Current Ratio (TTM)	0.11x	9.23x
Quick Ratio (TTM)	0.11x	8.81x
Debt/Equity (TTM)	1.38x	0.08x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.66	3.63
52W Performance	12.7%	-72.5%
YTD Performance	-44.7%	-51.4%
% from 52W High	-77.8%	-77.9%
% from 52W Low	17.5%	9.2%
Efficiency & Yields
Asset Turnover (TTM)	0.07x	0.07x
FCF Yield (TTM)	-19.4%	-35.3%
Earnings Yield (TTM)	-144.2%	-42.4%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-484.6	0.0
EV/GP/RG	N/A	N/A
Ticker research	View ARMP research	View SPRB research

Valuation

P/S Ratio

ARMP

24.04x

SPRB

26.75x

EV/FCF

ARMP

-15.23x

SPRB

-0.75x

Growth & revenue

Revenue Growth TTM

ARMP

-19.3%

Forward Revenue Growth

ARMP

-35.3%

SPRB

-75.6%

Profitability & performance

Gross Margin

ARMP

0.0%

SPRB

0.0%

ROE

ARMP

-12000.0%

SPRB

-15540.0%

FCF Yield %

ARMP

-19.4%

SPRB

-35.3%

52-Week Performance

ARMP

12.7%

SPRB

-72.5%

Detailed metrics comparison

ARMP

Armata Pharmaceuticals Inc

SPRB

Spruce Biosciences, Inc

Market Cap

ARMP$133M

SPRB$121M

Enterprise Value

ARMP$393M

SPRB$32M

Price

ARMP$3.63

SPRB$44.05

P/E Ratio

ARMPN/A

SPRBN/A

P/S Ratio

ARMP24.04x

SPRB26.75x

EV/Sales

ARMP70.87x

SPRB8.59x

EV/EBITDA

ARMP0.00x

SPRB0.00x

P/B Ratio

ARMP6.85x

SPRB1.57x

P/FCF Ratio

ARMPN/A

SPRBN/A

EV/FCF

ARMP-15.23x

SPRB-0.75x

PEG Ratio

ARMPN/A

SPRBN/A

Forward P/E (NTM)

ARMPN/A

SPRBN/A

Forward P/S (NTM)

ARMPN/A

SPRBN/A

Revenue (TTM)

ARMP$6M

SPRB$0

Revenue Growth (YoY)

ARMP-19.3%

SPRBN/A

Forward Rev Growth

ARMP-35.3%

SPRB-75.6%

Gross Margin (TTM)

ARMP0.0%

SPRB0.0%

Operating Margin (TTM)

ARMP0.0%

SPRB0.0%

EBITDA Margin (TTM)

ARMP-603.4%

SPRB0.0%

Net Margin (TTM)

ARMP-3467.0%

SPRB0.0%

FCF Margin (TTM)

ARMP-465.3%

SPRBN/A

Net Income (TTM)

ARMP$-192M

SPRB$-51M

FCF (TTM)

ARMP$-26M

SPRB$-43M

EPS (TTM)

ARMP-$3.10

SPRB-$21.14

ROE (TTM)

ARMP-12000.0%

SPRB-15540.0%

ROA (TTM)

ARMP-23569.0%

SPRB-10167.0%

ROIC (TTM)

ARMP-8123.0%

SPRB-14349.0%

Cash

ARMP$24M

SPRB$96M

Debt

ARMP$284M

SPRB$7M

Net Cash/Debt

ARMP$-260M

SPRB$89M

Current Ratio (TTM)

ARMP0.11x

SPRB9.23x

Quick Ratio (TTM)

ARMP0.11x

SPRB8.81x

Debt/Equity (TTM)

ARMP1.38x

SPRB0.08x

Debt/Assets (TTM)

ARMP0.0%

SPRB0.0%

Interest Coverage (TTM)

ARMPN/A

SPRBN/A

Net Debt/EBITDA (TTM)

ARMP0.00x

SPRB0.00x

Beta

ARMP1.66

SPRB3.63

52W Performance

ARMP12.7%

SPRB-72.5%

YTD Performance

ARMP-44.7%

SPRB-51.4%

% from 52W High

ARMP-77.8%

SPRB-77.9%

% from 52W Low

ARMP17.5%

SPRB9.2%

Asset Turnover (TTM)

ARMP0.07x

SPRB0.07x

FCF Yield (TTM)

ARMP-19.4%

SPRB-35.3%

Earnings Yield (TTM)

ARMP-144.2%

SPRB-42.4%

Dividend Yield (TTM)

ARMPN/A

SPRBN/A

Rule of 40

ARMP-484.6

SPRB0.0

EV/GP/RG

ARMPN/A

SPRBN/A

Ticker research

View ARMP research View SPRB research

Metric	ARMP Armata Pharmaceuticals Inc	SPRB Spruce Biosciences, Inc
Market & Valuation
Market Cap	$133M	$121M
Enterprise Value	$393M	$32M
Price	$3.63	$44.05
P/E Ratio	N/A	N/A
P/S Ratio	24.04x	26.75x
EV/Sales	70.87x	8.59x
EV/EBITDA	0.00x	0.00x
P/B Ratio	6.85x	1.57x
P/FCF Ratio	N/A	N/A
EV/FCF	-15.23x	-0.75x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$6M	$0
Revenue Growth (YoY)	-19.3%	N/A
Forward Rev Growth	-35.3%	-75.6%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-603.4%	0.0%
Net Margin (TTM)	-3467.0%	0.0%
FCF Margin (TTM)	-465.3%	N/A
Net Income (TTM)	$-192M	$-51M
FCF (TTM)	$-26M	$-43M
EPS (TTM)	-$3.10	-$21.14
ROE (TTM)	-12000.0%	-15540.0%
ROA (TTM)	-23569.0%	-10167.0%
ROIC (TTM)	-8123.0%	-14349.0%
Financial Health
Cash	$24M	$96M
Debt	$284M	$7M
Net Cash/Debt	$-260M	$89M
Current Ratio (TTM)	0.11x	9.23x
Quick Ratio (TTM)	0.11x	8.81x
Debt/Equity (TTM)	1.38x	0.08x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.66	3.63
52W Performance	12.7%	-72.5%
YTD Performance	-44.7%	-51.4%
% from 52W High	-77.8%	-77.9%
% from 52W Low	17.5%	9.2%
Efficiency & Yields
Asset Turnover (TTM)	0.07x	0.07x
FCF Yield (TTM)	-19.4%	-35.3%
Earnings Yield (TTM)	-144.2%	-42.4%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-484.6	0.0
EV/GP/RG	N/A	N/A
Ticker research	View ARMP research	View SPRB research